The robust editing capabilities of PE present substantial therapeutic potential; for example, in a mouse model of Alpha-1 antitrypsin deficiency (AATD), PE successfully eliminated the pathogenic E342K mutation in SERPINA1 by executing A-to-G edits (Erion et al., 2025). The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.